2/2015
vol. 9
Recommendations for the prevention of surgical site infections and use of antibiotic therapy during preoperative nursing care in surgery departments
Justyna Cwajda-Białasik
,
Katarzyna Cierzniakowska
,
Pielęgniarstwo Chirurgiczne i Angiologiczne; 2: 56-72
Online publish date: 2015/07/06
Get citation
Introduction
Hospital-acquired (nosocomial) infections are a major problem faced by contemporary medicine. They occur across the world, both in hospitals of the lowest reference levels and in very specialized research and teaching hospitals in highly developed countries [1]. The most common clinical manifestation of infections identified in surgery departments are surgical site infections (SSI) which are currently defined as infections occurring up to 30 or 90 days after surgical intervention, depending on the operative procedure [2-4]. Despite improvements in prophylaxis SSI continue to be a considerable clinical problem, as they result in increased morbidity and mortality, prolong hospitalization and increase costs of hospital treatment. The most serious consequences are observed among patients treated in intensive care units and surgery departments after abdominal operative procedures or cardiac operations. SSI accompany approx. 3% of all surgical procedures, and affect 20% of patients undergoing emergency operations due to acute abdominal illnesses. The incidence of SSI may reach 20% depending on the surgical procedure, criteria of follow-up monitoring and quantity of collected data [5]. Therefore, it is necessary to monitor risk factors on an ongoing basis, taking into account patient condition, type of procedure and hospital environment, in order to minimize the incidence of infections [3, 6].
Authors specializing in this subject area [3, 6, 7] point out that an increased number of SSI and severe infections is associated with a range of factors including:
• performance of increasingly complex operations in elderly patients having multiple coexisting diseases (ASA classes III, IV and even V),
• development of transplant surgery which inevitably requires immunosuppression,
• use of a variety of implants (meshes, prostheses),
• performance of operations in patients with impaired immunity,
• broad-spectrum antibiotic therapy resulting in increased microbial resistance [8, 9].
Furthermore, the emergence of increasingly narrow medical specializations leads to high rates of patient transfer between units and between hospitals, potentially resulting in an elevated incidence of hospital-acquired infections [8, 9].
Definitions of healthcare-associated infections (HAI) which are in force in all EU Member States and collaborating countries were first developed in 2009 by a team of experts appointed by the European Centre for Disease Prevention and Control (ECDC). The experts were tasked with unifying the criteria used for the diagnosis of infections. They are applied during point surveying and in the determination of incidence in long-term monitoring. Detailed criteria for the diagnosis of infections, including SSI, were defined in the Polish National Programme of Antibiotic Protection (National Programme of Antibiotic Protection for 2011-2015) [10,11]. Guidelines adopted in the documents referred to above are based on SSI definitions used by IPSE/HELICS (Improving Patient Safety in Europe) and U.S. CDC (Centres for Disease Control and Prevention). The guidelines distinguish three types of SSI:
• SSI type 1 (superficial) – involve only superficial tissues, i.e. the skin and subcutaneous tissue at the incision site,
• SSI type 2 (deep) – infections of deep tissues down to and/or involving muscle fascia at the incision site,
• SSI type 3 (organ/space) – infections involving any part of the body other than the incision site, e.g. an organ or body cavity which is in direct contact with the surgical site.
In addition to SSI location, the current guidelines also include diagnostic criteria and monitoring periods which differ depending on SSI type, as shown in Table 1. The table compares the definitions which were originally proposed and promoted worldwide by CDC: first published in CDC recommendations in 1999 [2, 12] and then revised in 2013 [2-4]. It needs to be noted that the revised classification no longer mentions implant use and introduces variable time frame criteria for SSI types 2 and 3 (30 or 90 days) depending on the performed surgical procedure. The procedures requiring a 90-day monitoring period were supplemented e.g. with knee and hip arthroplasty, herniorrhaphy, craniotomy, CABG (coronary artery bypass graft), breast surgery, open repositioning of fractures and peripheral vascular procedures. Also, relatively detailed procedures were introduced for reporting SSI in cases requiring two incisions at two different sites during a single procedure (e.g. harvesting of the saphenous vein for CABG). CDC guidelines also differentiate between primary and secondary SSI depending on whether infection is identified in the first or subsequent wound during a procedure involving multiple incisions [2].
Risk factors for SSI
A number of factors have been identified that have a direct effect on the incidence of infectious complications after operative procedures. They can be divided into environmental, patient-associated and surgery-associated factors. Some can be eliminated or minimized, however others are non-modifiable.
Factors increasing the risk of SSI include [3, 9, 13]:
• patient-dependent factors: different clinical conditions, chronic and systemic diseases reducing the effectiveness of a systemic immune reaction; foci of infection including chronic inflammatory states;
• factors related to the operative site including:
– factors increasing the risk of endogenous contamination e.g. as a result of opening of the gastrointestinal tract or transfer of pathogens from the patient’s skin and mucous membranes;
– factors increasing the risk of exogenous contamination related e.g. to an extensive or long-term exposure of the operative site or inappropriate/insufficient postoperative wound care;
– reoperations impairing local immune response and affecting the process of wound healing (e.g. as a result of excessive tissue traumatization, presence of foreign bodies, haematoma, drainage).
– factors related to the microbiological infectious agent (pathogen species, degree of virulence, antibiotic sensitivity, source of origin and immediate contamination), according to the formula:
Dose of microbiological contamination
× virulence
Risk of SSI =
Patient immunity
The risk of SSI is considered when the wound contamination level is 105 CFU/g of tissue (CFU = colony-forming units) [14], though a lower value can be considered in situations involving the implantation of a foreign material into the body of a patient [12]. The diagnosis of SSI should include the virulence of pathogens correlated with their toxin-producing ability or other factors increasing the capacity to invade or damage tissues. The mortality rate among patients infected with highly virulent strains such as leukocidin-producing S. aureus or erythrogenic toxin-producing Streptococcus pyogenesI, can be 74% [15].
The hospital is a specific environment in which infections occur much more frequently because treatment is provided concurrently, in a limited space, to patients with and without infection and with impaired immunity due to disease [6]. Therefore, before performing an operative procedure it is vital to eliminate or minimize as many SSI risk factors as possible.
Among multiple risk factors under analysis, there are several factors demonstrating a particularly strong correlation with the emergence of SSI. They are, among others, factors related to the general condition of the patient including [16-21]:
• age (> 65 years of age, newborns),
• smoking,
• obesity,
• circulatory system diseases, e.g. atheromatosis,
• other coexisting diseases, e.g. chronic obstructive pulmonary disease (COPD), diabetes, chronic kidney failure,
• malnutrition, hypoalbuminaemia,
• alcoholism,
• immune disorders,
• presence of foci of necrosis or skin infection.
• Literature on the topic also mentions factors associated with the operative procedure [12, 22]:
• type of patient admission,
• duration of hospitalization,
• preparation of the operative site,
• prolonged operative procedure,
• surgical site (e.g. groin, anal area),
• drain placed in the area of the postoperative wound,
• postoperative accumulations (e.g. haematomas) in the wound area,
• implantation of a foreign material (metal fusion material, hip prosthesis, vascular prosthesis, mesh made of an artificial material),
• intubation and controlled ventilation,
• central vascular catheters,
• haemodialysis procedures,
• gastric tube,
• tracheostomy tube,
• urinary catheters,
• loss of circulating blood volume and blood transfusion,
• improper hand hygiene by medical personnel engaged in the surgical procedure.
The occurrence of an infection is also frequently conditional on the pathogenic species and strain. The most common pathogens identified in surgical infections are microbial components of normal skin flora of patients and members of the operating team. They are the cause of surgical infections in over 50% of cases. Staphylococcus aureus and coagulase-negative staphylococci (CNS) are the most common aetiology of SSI and are detected in around 17-25% of cases [23]. Other pathogens include Escherichia coli (in 8% of cases), strains of Enterococcus spp. (in ca. 12% of cases), streptococci (in 6%), strains of Klebsiella spp., and anaerobic bacteria (e.g. Bacteroides fragilis). The proportions of different pathogens in SSI depend on the procedure. Pathogens can also originate in preoperative infections in locations beyond the operative site, particularly in patients during the placement of prosthesis or a different implant type. Furthermore, microorganisms causing SSI can come from exogenous sources – not only from members of the operating team but also from the operating room environment, tools and materials brought into the sterile field during surgical procedures. They are predominantly aerobes, especially Gram-positive bacteria, staphylococci and streptococci [12, 24]. Non-spore forming anaerobic bacteria (Bacteroides spp., PeptostreptococcusI spp.), clostridia causing gas gangrene, particularly the species Clostridium perfringens (especially in ischaemic tissues), are characteristic of infections developing after abdominal surgery. Pseudomonas aeruginosa and Acinetobacter baumannii trigger highly treatment-resistant SSI due to their multiresistance to antibiotics. The increasing number of SSI associated with antibiotic-resistant pathogens is a consequence of the increased number of patients with severe underlying diseases or immunodeficiency, and the use of broad-spectrum antibiotics [3, 24]. Serratia spp. rods are usually non-pathogenic, however in patients with impaired immunity they are pathogenic microbes. Organisms isolated from abscesses and fistulas also include fungi, e.g. Histoplasma, Coccidioides and Candida [9, 23].
Classification of wound cleanliness based on Cruse
One of the widely used SSI risk assessment scales is the classification of wounds which takes into account the degree of cleanliness of the operative site and the incidence of infections. The classification was proposed by the American College of Surgeons in the 1960s. However, the classification does not make it possible to precisely determine the likelihood of SSI, as it only describes one of multiple risk factors for SSI [25, 26].
Clean wound – a result of planned surgery with primary wound closure not requiring drainage, without signs of infection and inflammatory process in the operative site, without any contact with the alimentary, respiratory and urogenital systems. The group comprises e.g. orthopaedic, vascular and cardiac procedures. The incidence of infections in this class of wounds is 2-12% [25].
Clean contaminated wound – a result of surgery involving the opening of the alimentary, respiratory and urogenital systems under controlled conditions, combined with the entry into the viscera (stomach, gallbladder, intestines). Procedures classified in this group include appendectomy, procedures within the urogenital tract without urinary infections, procedures within the biliary tract without signs of biliary infections, procedures performed in the stomach, hysterectomy or surgical procedures in the nasopharyngeal cavity, reoperation within 7 days after clean surgery, blunt trauma. The incidence of infections in this class of wounds is 2-10% [25].
Contaminated wound – a fresh traumatic wound; an operation performed with a break in aseptic technique and intraoperative spillage from the gastrointestinal tract or an inflammatory process other than an infection within the operative site (e.g. appendectomy for non-perforated appendicitis, cholecystectomy for cholecystitis). A penetrating trauma occurring within < 4 hours after surgery, chronic wound to be covered by a graft. At 10-20% [25], the incidence of SSI in this category of wounds is higher than in clean contaminated wounds.
Dirty infected wound – an old traumatic wound with necrotic tissues, involving an active inflammation and presence of pus; penetrating trauma > 4 hours; preoperative perforation of the alimentary tract, biliary system and urinary tract. The operative site is in constant contact with the source of infection. The incidence of infections in this class of wounds ranges between 10 and 40% [4, 9, 12, 23, 25, 26].
A significant role in reducing the incidence of SSI in surgery departments is played by the awareness of risk and accurate modification of risk factors. It is vital to adopt a multi-faceted approach taking account of mutual interactions and dynamics of individual pre-, intra- and postoperative factors. Establishing a potential cause of SSI is difficult because a range of factors/causes can be involved. A crucial element of SSI prevention is preoperative preparation of the patient and a clean environment in which the patient stays from the time of hospital admission until the completion of treatment. The preparation of patients for surgical procedures comprises a number of stages and activities [13, 27].
Perioperative antibiotic prophylaxis
Based on information given in source documents [28, 29], the majority of operative procedures performed in hospitals do not require perioperative antibiotic prophylaxis (PAP). Each hospital should develop its own PAP rules adjusted to the types of surgical procedures performed in a given facility, so that every person engaged in the care of surgical patients is provided with clear information regarding indications, drug selection, dosage regimen and duration of treatment. The drugs of choice for the majority of procedures which require PAP are first-generation cephalosporins (cefazolin) or second-generation cephalosporins (cefuroxime, alternatively cefamandol) [28, 29]. For some surgical procedures, cephalosporins combined with metronidazole are recommended. Other drugs can be used for PAP practically only in carriers of methicillin-resistant Staphylococcus aureus (MRSA), patients who are allergic to beta-lactam antibiotics (immediate hypersensitivity reactions), in selected urological procedures and in ophthalmology. Dosage regimens of the main drugs used for PAP together with the times of administration of the next intraoperative dose are listed in Table 2.
Recommendation 1
The preparation of patients before planned operative procedures should begin in the outpatient setting.
Rationale
An extended period of patient hospitalization before an operation is connected with the risk of colonization with hospital strains which already occurs during 24-48 hours after patient admission to hospital. Study results justify early commencement of preparatory activities and provision of comprehensive education to patients at the stage of pre-hospital care. The above applies in particular to elective and planned procedures [3, 31]. During the period of preparation for surgery in the outpatient setting, patients should receive accurate and clear information on ways to reduce risk factors for SSI including the manner and time of preparation of the operative site, good hygiene of the whole body, treatment of dental caries, removal of calculus, limitation of the number of visitors during hospitalization (especially those with various types of infections, e.g. in the upper respiratory tract) [13, 31]. Before a scheduled operation, including in particular cardiac, vascular and other procedures that require using artificial implants, every patient should arrange a standard dental appointment in order to treat diseased teeth, extract dead teeth and remove calculus. The authors of the recommendations also suggest that before planned cardiac or vascular surgery the “cleanliness” of the oral cavity should be additionally confirmed by a written certificate issued by a dentist [32].
Practical implications
An assessment of the general physical and mental condition of the patient in the outpatient setting makes it possible to identify risk factors for infections and implement educational activities that are targeted at prophylaxis and conscious participation of the patient in the process of treatment.
Recommendation 2
Assessment of SSI risk and identification of factors associated with risk increase should be performed in every patient prepared for an operative procedure.
Rationale
An assessment of the risk of infection is an extension of medical history-taking and physical examination which aims to estimate risks associated with the scope of activities planned for the patient’s hospitalization.
There are risk indices developed specifically for the assessment of SSI risk, of which the most common are SENIC (Study of the Efficacy of Nosocomial Infection Control) and NNIS (National Nosocomial Infections Surveillance System).
SENIC is an index based on four risk factors:
• operation on the abdomen,
• operation lasting for more than two hours,
• contaminated or dirty operative site,
• more than three components of the final medical diagnosis [8, 22].
NNIS is an index focusing in particular on the assessment of three risk factors:
• contaminated or dirty operative site,
• operation lasting more than 75% of time set for a given procedure,
• patient’s general condition score > III in the ASA scale (American Society of Anaesthesiologists) [8, 10, 33-35].
An accumulation of factors assessed on the basis of both indices means that a patient is under an increased risk of SSI [8, 24, 36]. Entering information about the risk of infection assessed on hospital admission in the medical records of patients is a requirement resulting from the legal acts in force [37, 38]. A significant element of preparing patients for a surgical procedure is the identification of active infections including urinary tract infection, pneumonia, sinusitis, recurring boils and bedsores which are potential sources of contamination of the operative wound. Emergency procedures require empiric antibiotic therapy followed by targeted antibiotic therapy after results of microbiological tests become available [8, 30].
Practical implications
The task of a nurse, a specialist in surgical nursing as well as physicians and other members of the medical team is to identify primary and modifiable risk factors for infection in every patient, document them and follow all SSI prevention procedures which are in place in the unit.
Recommendation 3
Every patient is provided with a clean hospital bed and clean bedding.
Rationale
Reservoirs of pathogens in the hospital environment include bed frames and bedding, taps, hospital worktops and floors, door handles, curtains, stethoscopes, blood pressure monitor cuffs, tourniquets, ball pens, personnel ID badges and mobile phones. The most commonly isolated hospital pathogens are able to persist on these objects for up to several months under dry conditions and much longer in a humid environment [39].
The most effective method of bed decontamination is washing and disinfection in a washer-disinfector or cleaning the entire surface with a cleaning and disinfecting agent. In order to reduce the number of pathogens which are capable of surviving in an inanimate environment, hospital beds should preferably have mattresses with washable covers as well as pillows and duvets/blankets that can be washed at 93-95°C. They have breathable covers with washable surfaces. When no longer used by a patient, the pillow and duvet should be washed and disinfected (particularly after being used by a patient with a nosocomial infection or after the death of a patient, and each time after soiling with a biological material) [27].
Practical implications
The charge nurse is responsible for implementing and ensuring compliance of subordinate personnel with hygienic procedures applicable to the cleanliness of beds and bedding in the unit, and for providing disinfecting agents.
Recommendation 4
Every patient should have a whole-body bath with a detergent containing a substance with proven antibacterial and antifungal effectiveness on the day before surgery and in the morning of the day of the surgical procedure, and change into a clean hospital gown.
Rationale
The majority of surgical site infections are caused by components of the patient’s physiological microflora including CNS, Staphylococcus aureus, enterococci, Gram-negative rods and – less commonly – anaerobic bacteria [3]. Strains of species making up the patient’s natural skin microflora are the most frequent aetiology of SSI in clean wounds [40]. Appropriate preparation of the operative site, aimed at eradicating transient and reducing resident microflora, is one of the more important elements of hospital preparation. The procedure includes thorough washing of the area of the planned incision and the whole body with detergents containing an antiseptic [3, 9, 12, 41]. It has been demonstrated that a bath taken in the evening of the day preceding the operation followed by another bath in the morning on the day of surgery is a more effective approach than a single bath immediately before the surgical procedure. However, chlorhexidine has not been proven to be superior to other antiseptics used for preoperative baths [4, 42]. Studies comparing chlorhexidine baths with chlorhexidine-free soap baths (placebo) have failed to demonstrate a significant difference between two bath types in terms of SSI incidence [43]. Considering the above, it is vital to ensure that every patient has two baths prior to an operation. Single-use washing mitts, sponges or (single-use) sachets are recommended. Body areas that should be washed with particular care include the armpits, groins, crotch, buttocks, skin folds, navel (before abdominal and laparoscopic surgery) and hair. The navel area is a perfect habitat for microbial growth. Positive cultures were demonstrated in 88.6% of cases before navel disinfection, and in 17.3% also after disinfection. In 73.1% of cases, the same strains were cultured in both tests. Although skin disinfection before laparoscopy is not completely effective, it is not a factor affecting the incidence of SSI [44].
Patients should receive detailed information about the importance of taking two thorough preoperative baths with soap or a single bath with an antibacterial and antifungal substance, e.g. with an addition of octenidine hydrochloride, and other antiseptics with proven biocidal effectveness. Baths are used not only for hygienic (e.g. genital hygiene) and aesthetic reasons but primarily as a prophylactic measure. After taking a bath on the day of the operation the patient should receive a hospital gown of the type suited to the nature of the procedure and clinical conditions, and ensuring easy access to the surgical site and venous access (e.g. PVC) locations. The preferred option are cotton or disposable gowns which do not restrict the patient’s movements and easily soak up perspiration. The selection of hospital gowns or pyjamas should also take into account the comfort, dignity and intimacy of the patient [45].
Practical implications
A double preoperative bath with single-use sponges, washing mitts or (single-use) sachets and a detergent containing a substance with proven antibacterial and antifungal effectiveness, and clean hospital gowns, reduce the skin microflora and consequently decrease the incidence of surgical site infections. Hospital gowns should be washed at high temperatures in a laundry or, alternatively, disposable products should be used.
Recommendation 5
After each bath, patients should dry their body with a clean bath towel or a disposable towel. Washed hands should only be dried with disposable towels. Personal underwear and pyjamas should be clean and dry.
Rationale
Patients tend to repeatedly use the same bath towels brought from home for drying the body after taking a bath. However, multiple use of the same towels, which are often damp, is a factor predisposing to body colonization by a variety of microbes transferred from other areas (when one towel is used for drying both the upper and lower body) and pathogens multiplying in the damp towel fabric [13, 27]. Introducing cotton drapes (washable at high temperatures in a hospital laundry) or disposable towels for body drying in the perioperative period can be an alternative to the multiple use of the patient’s own towels.
Appropriate methods of hand drying, applied both by medical personnel and patients, play a key role in the entire process of hand washing and risk of microbial transfer. Hand drying with disposable towels has been shown to be associated with the lowest rate of pathogen spread in the air and pathogenic infections, e.g. after using the toilet, of all available drying methods. Disposable towels have the lowest microbial transfer rates and pose the lowest risk of cross-contamination when compared with hot air hand dryers, high speed hand dryers and textile tower rolls [46].
Practical implications
Using bath towels only once or applying disposable towels for body and hand drying, as well as wearing clean and dry personal underwear/pyjamas, are practices which reduce the risk of infection by pathogens propagating in a humid environment.
Recommendation 6
Hair removal from the operative site should be performed no sooner than 1-2 hours before the surgical procedure and only if hair might interfere with the operation.
Rationale
Hair removal should not be performed as a routine procedure in all surgical patients. If hair removal is necessary, CDC recommends using a safety razor with replaceable blades or a surgical clipper (removes hair ca. 1 mm above the skin surface). Hair should be removed immediately (between one and two hours) before the operative procedure [9, 47, 48]. Hair removal > 24 hours before surgery carries the risk of microcuts and epidermal colonization by pathogens. The likelihood of SSI also depends on the method of hair removal: it increases by 2.5% for mechanical shaving (razor blades and traditional disposable safety razors) and decreases by 1.4% for shaving with an electric razor and 0.9% when no shaving is performed.
Practical implications
Following the recommendations (indications for hair removal, time frame and method of hair removal) reduces the risk of operative site infection.
Recommendation 7
Nasopharyngeal decolonization should not be performed as a routine procedure in all Staphylococcus aureus carriers in the perioperative period.
Rationale
Before patient transfer to the operating suite, the recommended practice is rinsing the mouth with a solution removing biofilm which usually builds up on dental plate. However, routine eradication of pathogens inhabiting the nasopharyngeal cavity, including Staphylococcus aureus (60%), is not recommended [45, 49, 50]. Decolonization of Staphylococcus aureus from the nasopharyngeal cavity can be indicated/justified in specific patient groups, e.g. before cardiac and orthopaedic surgery and other procedures [13, 27, 31, 50].
Practical implications
Thorough oral hygiene and justified nasopharyngeal decolonization in carriers of Staphylococcus aureus reduces the incidence of infections originating in the nasopharyngeal cavity.
Recommendation 8
Before an operative procedure all patients should have their nutritional status evaluated according to a scale used by the hospital/unit. Patients at an increased risk associated with the nutritional status should be subjected to nutritional assessment. Emaciated and severely malnourished patients should receive nutritional treatment for 10-14 days prior to surgery even at the cost of delaying the planned operative procedure. Excluding the intake of solid foods before a procedure should not exceed 6 hours, however anaesthesiological recommendations for abstaining from food intake because of planned anaesthesia should be considered in each individual case.
Rationale
Upon admission to the unit, patients should be screened for their nutritional status using one of available scales: SGA (Subjective Global Assessment) (Annex 1) or NRS 2002 (Nutritional Risk Screening 2002) (Annex 2) [51]. Patients at an increased risk due to their nutritional status (e.g. diagnosed with cancer) should undergo nutritional assessment (nutritional interview, anthropometric measurements, biochemical tests, immune tests) [33]. The aim of nutritional assessment is to determine whether nutritional support should be provided or albumin and electrolyte deficiency should be corrected prior to surgery [52]. The nutritional regime and diets depend on the clinical condition of the patient, and the type and extensiveness of surgery [23]. According to guidelines developed by the European Society of Anaesthesiology, patients should not ingest any solid foods for at least six hours before planned surgery, and should not drink any fluids for two hours before the operation. However, anaesthesiological recommendations for abstaining from food and drink because of planned anaesthesia should be considered in each individual case. Many authors [49, 53, 54] are of the opinion that prior to an operative procedure patients should not avoid the intake of fluids for any longer than necessary.
Practical implications
The obligation to assess the nutritional condition of patients who are hospitalized for planned procedures stems from the Regulation of the Minister of Health of 22 November 2013 on guaranteed hospital treatment services (Annex 3).
An evaluation of the patient’s nutritional status and nutritional assessment make it possible to diagnose disorders and introduce appropriate nutritional support and/or correct deficiencies before performing an operative procedure.
The assessment should be performed by the attending physician or a member of the nutritional team, e.g. a nurse who has completed a specialist course in parenteral and enteral nutrition or a specialist in surgical nursing.
Recommendation 9
Patients with marked obesity should reduce their body weight before a planned operative procedure.
Rationale
There is a multifold increase in the risk of perioperative complications and SSI in patients with a high body mass index (BMI > 35). Obese individuals have been shown to have higher levels of bacterial contamination of the skin and develop intertrigo, oedema and vascular disorders predisposing to bacterial colonization and infections. The recommendation for obese patients is to reduce and stabilize their body weight, which includes consistent changes in lifestyle and nutritional habits. Typically, obese patients require prolonged and complex therapy, not only dietary but also psychological [3].
Practical implications
One of important elements of patient care is education focused on proper diet and regular exercise adjusted individually to the patient, monitoring of blood glucose levels, blood pressure measurements, BMI monitoring and emotional support for the patient. Obese patients should be referred to an obesity treatment outpatient clinic to receive care that helps with the loss of body weight.
Recommendation 10
Smoking patients should be provided with information about the adverse effects of nicotine and the need to refrain from smoking for at least 6-8 weeks before their planned operative procedure.
Rationale
A significant correlation has been demonstrated between smoking and septic complications in the perioperative period. Nicotine interferes with the healing of postoperative wounds by reducing the oxygen transport ability of haemoglobin and producing strong local vascular constriction, thus impairing the delivery of oxygenated blood to tissues [3, 35]. Cohort studies of smokers vs non-smokers have demonstrated a significantly higher incidence of postoperative complications including necrosis in the wound area, a delay or lack of progress in the process of healing, development of fistulas and hernias in the postoperative wound/scar (a two-fold risk increase in smokers). A significantly lower risk of SSI has been observed in people with no history of smoking [26, 56, 57]. A restrictive ban on smoking is validated by studies: partial oxygen pressure in healthy individuals after smoking two cigarettes within 15 minutes decreased in a statistically significant manner on average from 63% to 54.5% [58].
Practical implications
A physician/nurse informs the patient about the effects of nicotine on the human body including postoperative consequences. An assessment of the degree of nicotine dependence, motivation to quit smoking and reasons for breaking nicotine addiction is performed, and various strategies for stopping smoking are presented, e.g. nicotine replacement therapy, pharmacotherapy or behavioural therapy. A physician/nurse also counsels smoking patients about the availability of outpatient clinics specializing in addiction treatment.
Recommendation 11
Patients require the correction of systemic disorders resulting from coexisting diseases in the preoperative period.
Rationale
The number of coexisting diseases and their advancement exhibit a strong correlation with the development of SSI [3, 8]. Surgical risk evaluated as the ASA score of 3 or 4 indicates a poor general condition of the patient and an increased susceptibility to infection [17]. The most common clinical conditions and coexisting diseases which affect the risk of SSI include diabetes, atheromatosis, hypertension, cancer, kidney failure, malnutrition (particularly hypoalbuminaemia), inflammatory skin diseases and immunosuppression. The risk of SSI increases during certain therapies which are inevitable in the perioperative period, e.g. steroid therapy, antibiotic therapy and immunosuppressive treatment [3, 4, 9, 12, 42]. Diabetes has also been shown to cause a two- or even three-fold increase in the risk of SSI. The likelihood rises together with an increase in hyperglycaemia in the perioperative period. According to CDC guidelines, the level of post-meal glycaemia before a procedure should be maintained at < 200 mg/dl [4]. American Diabetes Association (ADA) emphasizes the importance of achieving an optimum level of glycosylated haemoglobin (HbA1c < 7%), and average pre-meal glucose level of 90-130 mg/dl, and post-meal glucose level < 180 mg/dl [59]. It is also vital to prepare the patient for self-control and appropriate dietary adjustments. Similar recommendations should also apply to patients with modifiable systemic disorders depending on their daily activities, health habits and lifestyle factors, e.g. patients with atheromatosis (regardless of clinical anatomical manifestations) and hypertension [56, 60].
Practical implications
Based on the ASA assessment of risk in surgical patients (Annex 4) performed by an anaesthesiologist, as well as other specialist consultations, a nurse implements medical diagnostic and therapeutic recommendations. In addition, a nurse monitors the vital signs of patients, controls glycaemia and provides patient care according to an individually arranged schedule.
Recommendation 12
Preoperative gastrointestinal preparation is recommended in procedures performed under regional anaesthesia.
Rationale
One of multiple components involved in the prevention of perioperative infections is bowel preparation for colorectal surgery. Although there are studies demonstrating that preoperative mechanical decontamination has no effect on the incidence of intestinal anastomotic leakage, development of abscesses or SSI in patients undergoing planned surgery [5], many medical centres continue to perform preoperative bowel cleansing with oral medicines as a standard procedure [61].
Mechanical bowel cleansing is contraindicated in patients with symptoms of gastrointestinal obstruction (tumours narrowing gastrointestinal lumen) and perforation.
Practical implications
The removal of faecal matter from the gastrointestinal system prevents the contamination of patients on the operating table and penetration of gastrointestinal pathogens into the peritoneal cavity during the period of paralytic ileus observed in every patient operated under general anaesthesia for 24-72 hours after surgery.
Recommendation 13
Each hospital should have in place guidelines for perioperative antibiotic prophylaxis.
Rationale
Cephalosporins used in PAP should be administered no sooner than 30 minutes prior to the procedure (0-30 minutes before skin incision) and in procedures performed under tourniquet ischaemia – 10-15 minutes before tourniquet placement. Medicines should preferably be administered in the operating suite, after the patient is placed in an appropriate position and anaesthesia is induced, e.g. when the operative site is being cleaned. Based on study results, the procedure lowers the risk of SSI [28, 29]. In the majority of cases, a single PAP dose is recommended, and PAP should not be used for longer than 48 hours. Prolonged use is recommended only in procedures involving the implantation of biomaterials. PAP administered for more than 24 hours has not been shown to have a superior efficacy [28, 29].
Practical implications
Medicines used for perioperative antibiotic prophylaxis should be available in the operating suite area.
Hospital guidelines regulating the administration of PAP should take into account the responsibilities and competencies of people involved in the process of treatment, and the method used for documentation purposes.
References
1. Sierocka A, Cianciara M. Monitorowanie zakażeń szpitalnych. Probl Hig Epidemiol 2010; 91: 323-328.
2. CDC/NHSN Protocol Clarifications. Centers for Disease Control and Prevention. Available at: 2013; http://www.cdc.gov/nhsn/pdfs/pscmanu-al/9 icurrent.pdf.
3. Gospodarek E, Szopiński J, Mikucka A. Zakażenie miejsca operowanego – postaci kliniczne, czynniki ryzyka, profilaktyka, etiologia, diagnostyka. Forum Zakażeń 2013; 4: 275-282.
4. Surgical Site Infection (SSI) Event. Centers for Diesease Control and Prevention (online) 2014. Available at: http://www.cdc.gov/nhsn/PDFs/pscmanual/9pscssicurrent.pdf.
5. Saha AK, Chowdhury F, Jha AK, et al. Mechanical bowel preparation versus no preparation before colorectal surgery: A randomized prospective trial in a tertiary care institute. J Nat Sci Biol Med 2014; 5: 421-424.
6. Gospodarek E, Mikucka A. Czynniki ryzyka zakażeń miejsca operowanego. Zakażenia 2005; 3: 87-91.
7. Szczypta A, Bulanda M. Nadzór nad zakażeniami miejsca operowanego. Forum Zakażeń 2012; 3: 187-194.
8. Bielecki K. Zakażenia chirurgiczne. Wydawnictwo Medyczne Borgis, Warszawa 2007.
9. Montewka M, Skrzek A, Plewik D, et al. Zakażenia miejsca operowanego – charakterystyka czynników ryzyka, endogennych źródeł zakażenia i metody zapobiegania. Post Mikrobiol 2012; 51: 227-235.
10. Dziennik Urzędowy Unii Europejskiej L262/1 Decyzja Wykonawcza Komisji z dnia 8 sierpnia 2012 r. zmieniająca decyzję 2002/253/WE ustanawiającą definicje przypadku w celu zgłaszania chorób zakaźnych do sieci wspólnotowej na podstawie decyzji nr 2119/98/WE Parlamentu Europejskiego i Rady (2012/506/UE).
11. Narodowy Program Ochrony Antybiotyków. Definicje zakażeń szpitalnych. Narodowy Program Ochrony Antybiotyków na lata 2011–2015. Dostępne na: http://www.antybiotyki.edu.pl/pdf/Definicje-zakazen-szpitalnych.pdf.
12. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC). Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999; 27: 97-132.
13. Cwajda-Białasik J, Szewczyk MT, Mościcka P, et al. Znaczenie edukacji i opieki pielęgniarskiej w profilaktyce długoterminowej zakażenia miejsca operowanego. Część 1. Rola pielęgniarki podstawowej opieki zdrowotnej i pielęgniarki chirurgicznej w przygotowaniu chorego do planowego zabiegu operacyjnego. Forum Zakażeń 2014; 5: 217-223.
14. Krizek TJ, Robson MC. Evolution of quantitative bacteriology in wound management. Am J Surg 1975; 130: 579-584.
15. Dohmen PM. Influence of skin flora and preventive measures on surgical site infection during cardiac surgery. Surg Infect (Larchmt) 2006; 7 Suppl 1: S13-7.
16. Kaye KS, Schmit K, Pieper C, et al. The effect of increasing age on the risk of surgical site infection. J Infect Dis 2005; 191: 1056-1062.
17. May AK, Kauffmann RM, Collier BR. The place for glycemic control in the surgical patient. Surg Infect (Larchmt) 2011; 12: 405-418.
18. Neumayer L, Hosokawa P, Itani K, et al. Multivariable predictors of postoperative surgical site infection after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg 2007; 204: 1178-1187.
19. Olsen MA, Mayfield J, Lauryssen C, et al. Risk factors for surgical site infection in spin surgery. J Nur Surg 2003; 98 (2 Suppl): 149-155.
20. Sikora A, Kozioł-Montewka M, Montewka M. Okołooperacyjna profilaktyka antybiotykowa (OPA) w chirurgii. Przegląd Lekarski 2011; 68: 280-283.
21. Xue DQ, Qian C, Yang L, Wang XF. Risk factors for surgical site infections after breast surgery: a systematic review and meta-analysis. Eur J Surg Oncol 2012; 38: 375-81.
22. Stanisławek A, Wyroślak B, Sołowiej K, et al. Czynniki ryzyka zakażenia i najczęstsze patogeny miejsca operowanego u chorych na choroby nowotworowe – doniesienia wstępne. Journal of Health Sciences 2013; 3: 399-406.
23. Meakins J. Prevention of postoperative infection. Basic surgical and perioperative consideration. ACS Surgery: Principlesand Practice 2008.
24. Walraven C, Musselman R. The surgical site infection risk score (SSIRS): a model to predict the risk of surgical site infections. PLOS One 2013; 8: e67167.
25. Cruse P, Ford R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Sur Clin North Am 1980; 60: 27-40.
26. Siczyńska B, Miętkiewicz S, Dyk D. Analiza czynników ryzyka zakażenia oraz możliwość ich modyfikacji. Piel Chir Angiol 2014; 2: 56-61.
27. Ciuruś M. Przygotowanie pacjenta do zabiegu jako proces redukcji ryzyka zakażenia miejsca operowanego. Forum Zakażeń 2014; 5: 171-176.
28. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013; 70: 195-283.
29. Hryniewicz W, Kulig J, Ozorowski T, et al. Stosowanie antybiotyków w profilaktyce okołooperacyjnej. Narodowy Program Ochrony Antybiotyków, Warszawa 2011.
30. Dzierżanowska D. Patogeny bakteryjne zakażeń szpitalnych. W: Zakażenie szpitalne. Dzierżanowska D (red.). &-medica Press, Bielsko-Biała 2008; 90: 297-339.
31. Karwacka M, Mączyńska AT, Świerczyńska B. Przygotowanie pacjenta do zabiegu operacyjnego jako profilaktyka zakażeń miejsca operowanego. Forum Zakażeń 2013; 4: 73-76.
32. Denisewicz I, Brykczyński M, Karczmarczyk A, et al. Rola lekarza rodzinnego w przygotowaniu pacjenta do operacji kardiochirurgicznej. Med Og Nauk Zdr 2012; 18: 147-153.
33. Rogulska A. Zasady prawidłowego żywienia chorych w szpitalach. Wyd. Instytut Żywności i Żywienia, Warszawa 2011.
34. Gandhi T, Flanders S, Markovitz E, et al. Importance of urinary tract infection to antibiotic use among hospitalized patients. Infect Control Hosp Epidemiol 2009; 30: 193-195.
35. Longrois D, Hoeft A, De Hert S. 2014 European Society of Cardiology/European Society of Anaesthesiology guidelines on non-cardiac surgery: cardiovascular assessment and management: A short explanatory statement from the European Society of Anaesthesiology members who participated in the European Task Force. European Journal of Anaesthesiology 2014; 31: 517-573.
36. Ashok R, Lakshmi V, Sastry RA. Applicability of risk indices on surgical site infections in abdominal surgery. Asian Journal of Biomedical and Pharmaceutical Sciences 2013; 3: 20-22.
37. Rozporządzenie Ministra Zdrowia z dnia 27 maja 2010 r. w sprawie sposobu dokumentowania realizacji działań zapobiegających szerzeniu się zakażeń i chorób zakaźnych oraz warunków i okresu przechowywania tej dokumentacji (Dz. U. z 2008 r. Nr 100 poz. 645 z późn. zm.).
38. Ustawa z dnia 5 grudnia 2008 r. o zapobieganiu oraz zwalczaniu zakażeń i chorób zakaźnych u ludzi (Dz. U. z 2008 r. Nr 234 poz. 1570 z późn. zm.).
39. Łukaszuk M, Marciniak R, Drews M. Zapobieganie zakażeniom chirurgicznym i ich leczenie – postępy 2012. Medycyna Praktyczna. Chirurgia 2013; 3: 7-16.
40. Mirzaei R, Shahriary E, Qureshi MI, et al. Quantitative and qualitative evaluation of bio-aerosols in surgery rooms and emergency department of an educational hospital. Jundishapur J Microbiol 2014; 7: e11688.
41. Sorensen LT. Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg 2012; 147: 373-383.
42. Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical site infections. Ann Surg 2011; 253: 1082-1093.
43. Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2015; 2: CD004985.
44. Bieńkowski M, Gospodarek E, Olejarz A, Deptuła A. The evaluation of skin disinfection efficacy and its influence on prevalence of surgical site infections in patients subjected to laparoscopic cholecystectomy. Med Dośw Mikrobiol 2007; 59: 183-191.
45. Surgical Site Infection: Prevention and Treatment of Surgical Site Infection. NICE guidelines [CG74], October 2008. Available at: http;//www.nice.org.uk/Guidance/CG74.
46. Best EL, Redway K. Comparison of different hand-drying methods: the potential for airborne microbe dispersal and contamination. J Hosp Infect 2015; 89: 215-217.
47. Bielawska A, Bączyk G, Pieścikowska J. Przygotowanie pola operacyjnego jako niezbędny element przygotowania chorego do operacji. Piel Chir Angiol 2010; 4: 111-113.
48. Zalecenia konsultanta krajowego w dziedzinie pielęgniarstwa epidemiologicznego dotyczące redukcji ryzyka rozwoju zakażenia miejsca operowanego. Polskie Stowarzyszenie Pielęgniarek Epidemiologicznych. Dostepne na: http://www.pspe.pl/files/opinia_KK_7.pdf.
49. Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Eng J Med 2010; 362: 9-17.
50. van Rijen MM, Bonten M, Wenzel RP, et al. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carierage: a systematic review. J Antimicrob Chemiother 2008; 61: 254-261.
51. Rozporządzenie Ministra Zdrowia z dnia 22 listopada 2013 r. w sprawie świadczeń gwarantowanych z zakresu leczenia szpitalnego.
52. Zasady prawidłowego żywienia chorych w szpitalach. Jarosz M (red.). Wyd. Instytut Żywności i Żywienia, Warszawa 2011.
53. Ochocka B. Zalecenia Konsultanta Krajowego w Dziedzinie Pielęgniarstwa Epidemiologicznego. Zakażenia 2011; 11: 1-110.
54. Tojek K, Frasz J, Szewczyk MT, et al. Ocena stanu odżywienia pacjentów hospitalizowanych w Katedrze i Klinice Chirurgii Ogólnej na podstawie Formularza NRS 2002. Piel Chir Angiol 2009; 4: 144-150.
55. Smith I, Kranke P, Murat I, et al. Głodzenie w okresie okołooperacyjnym dorosłych i dzieci – wytyczne Europejskiego Towarzystwa Anestezjologii. Opieka Okołooperacyjna 2011; 1: 8-22.
56. Spannbauer A, Madejczyk M, Chwała M, et al. Jaki jest styl życia pacjentów z miażdżycowym niedokrwieniem tętnic kończyn dolnych kwalifikowanych do chirurgicznych zabiegów naprawczych pomostowania tętnic? Piel Chir Angiol 2015; 1: 28-35.
57. Sztuczka E, Szewczyk MT. Ocena motywacji chorych z miażdżycą tętnic kończyn dolnych do zaprzestania palenia tytoniu na podstawie testu Niny Schneider. Piel Chir Angiol 2008; 1: 5-11.
58. Ziaja D, Biolik TG, Orawczyk H, et al. Dynamika zmian prężności tlenu i dwutlenku węgla u palaczy papierosów. Chirurgia Polska 2008; 10: 670.
59. American Diabetes Association standards of medical care in diabetes: 2008. Diabetes Care 2008; 31 (Suppl 1): S12-S54.
60. Cierzniakowska K, Westphal B, Szewczyk MT. Zachowania zdrowotne chorych ze zwężeniem tętnic szyjnych. Piel Chir Angiol 2011; 4: 211-217.
61. Willis S, Schumpelick V. Resekcyjne zabiegi jelita grubego z dostępu przez laparotomię. Medycyna Praktyczna. Chirurgia 2013; 5: 9-21.
62. Townsend CM Jr, Beauchamp RD, Evers BM, Mattox KL. Chirurgia Sabiston. Tom 1. Wyd. I polskie. Popiela T (red. wyd. pol.). Elsevier Urban & Partner, Wrocław 2010.
Copyright: © 2015 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License ( http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
|
|